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bjectives The objective of this study was to compare 2 manual thrombus aspiration catheters in
nselected patients with ST-segment elevation myocardial infarction.
ackground Distal embolization is common during percutaneous coronary intervention in ST-
egment elevation myocardial infarction and can induce impaired myocardial perfusion. Several aspi-
ation thrombectomy devices have been introduced to prevent distal embolization, however, with
onﬂicting clinical results. Currently, it is unclear to what extent this variance in outcome can be
xplained by device-related factors, such as internal lumen size.
ethods We performed a prospective cohort study in which patients undergoing primary percuta-
eous coronary intervention were treated with a large-internal-lumen catheter (Diver, Invatec,
oncadelle, Italy). Outcomes were compared with a matched population of the Thrombus Aspiration
uring Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS) trial, in
hich patients were treated with a medium-sized catheter (Export, Medtronic, Minneapolis, Minne-
ota). A histopathological analysis was performed of retrieved material.
esults A total of 160 patients, treated with the Diver (n  80) or Export (n  80) aspiration cathe-
er, were enrolled. Effective thrombus aspiration was seen in 70.3% of the patients treated with the
iver catheter versus 81.8% with the Export catheter (p  0.10) No signiﬁcant difference was found
n myocardial blush grade or electrocardiographic outcome between the 2 devices. Size distribution
f retrieved thrombotic particles was similar per device. Erythrocyte-rich thrombi were found in
4.8% of the cases and were predominately seen in patients with low initial Thrombolysis In Myo-
ardial Infarction ﬂow grade (p  0.008).
onclusions A larger internal lumen diameter does not result in retrieval of larger thrombotic parti-
les, nor in improved angiographic or electrocardiographic outcomes. (J Am Coll Cardiol Intv 2008;
:258–64) © 2008 by the American College of Cardiology Foundation
rom the *Department of Cardiology and †Department of Pathology, University Medical Centre Groningen, University of
roningen, the Netherlands.anuscript received February 8, 2008; revised manuscript received March 7, 2008, accepted March 15, 2008.
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259istal embolization is common during percutaneous coro-
ary intervention (PCI) in ST-segment elevation myocar-
ial infarction (STEMI) and can induce impaired myocar-
ial perfusion (1,2). Several aspiration and thrombectomy
evices have been introduced to prevent distal embolization.
hese include the Diver (Invatec, Roncadelle, Italy), Export
Medtronic, Minneapolis, Minnesota), Probing (Boston
cientific, Natick, Massachusetts), Pronto (Vascular Solu-
ions, Minneapolis, Minnesota), and Rescue catheters (Bos-
on Scientific, Natick, Massachusetts) (3–8). The ideal
spiration catheter should be rapidly exchangeable, good
eliverable (also in small diameter and tortuous culprit
essels), and at the same time have sufficient lumen size to
See page 265
spirate thrombus material. Based on internal lumen diam-
ter, aspiration catheters can be subdivided into 3 size
roups: large (Diver, 0.062 inch; Pronto, 0.065 inch),
edium (Export, 0.041 inch; Rescue, 0.042 inch), and small
Probing, 0.018 inch). Currently, it is unknown whether
arge-lumen-diameter catheters are able to aspirate larger
hrombotic components when compared with smaller sized
nes. Retrieval of larger particles could improve the efficacy
f thrombus aspiration, leading to better myocardial perfu-
ion after primary PCI. On the other hand, a larger lumen
iameter could influence handling characteristics and device
afety.
To test the hypothesis that a large-lumen-diameter cath-
ter is capable of aspirating larger thrombotic components,
e performed a prospective cohort study in which patients
ndergoing primary PCI were treated with a large-diameter
atheter (Diver catheter). Further, because histopathological
nalysis of aspirated debris has only been performed in small
nd selected study populations (8–10), we also performed a
istopathological assessment of retrieved material.
Histopathological, angiographic, and clinical outcomes
ere compared with a matched population of the TAPAS
Thrombus Aspiration during Percutaneous coronary inter-
ention in Acute myocardial infarction Study), in which
atients were treated with a medium-sized catheter (Export
atheter) (3).
aterials and Methods
nrollment in the TAPAS trial ended December 2006 (3).
rom January 2007 to March 2007, all patients who
nderwent PCI in a native vessel for STEMI were included
n this prospective study. Inclusion and exclusion criteria
ere similar to that for the TAPAS trial. In summary,
atients were considered eligible for inclusion when they
ad symptoms suggesting acute myocardial ischemia 30
in, time from symptom onset was 12 h, and ST-egment elevation 0.1 mV in 2 contiguous leads was Tresent on the electrocardiogram (ECG). Patients were
xcluded when they underwent rescue PCI after thrombol-
sis, had known existence of a disease with life expectancy
6 months, or no informed consent was given.
Consecutive patients treated with the Diver catheter were
atched with patients included in the TAPAS study, in
hich thrombus aspiration with the Export catheter was
ttempted (3). Matching was based on the following vari-
bles: gender, initial Thrombolysis In Myocardial Infarction
TIMI) flow grade 1, age 5 years, and segment culprit
esion.
The primary end point is incidence of aspirated throm-
otic components 1 mm. Secondary end points are myo-
ardial blush grade, ST-segment elevation resolution, per-
istent ST-segment elevation, enzymatic infarct size,
ostprocedural distal embolization, and major adverse car-
iac events at 30 days.
The angiographic, histopathological, and electrocardio-
raphic methods used in this study were similar to those
sed in the TAPAS trial (3).
escription of the thrombus-
spiration catheters. The PCI
as performed using standard
ercutaneous techniques. The
xport aspiration catheter
Medtronic) and the Diver Clot
xtraction (Invatec) are both
-F compatible thrombus aspi-
ation catheters. The Export has
n oblique aspiration tip design,
ith an aspiration lumen of
.041 inch. The Diver has a
istal aspiration lumen of 0.062.
n both aspiration catheters, suc-
ion is provided by hand with a
ockable 20-ml syringe. All interventional cardiologists were
xperienced in the usage of manual thrombus aspiration
atheters. In addition, because the usage of both aspiration
atheters is similar, no learning curve was expected in the
iver group.
edication. Before PCI, the patient was treated with aspi-
in (a bolus of 500 mg), intravenous heparin (5000 IU), and
lopidogrel (a loading dose of 600 mg). Adjunctive therapy
ncluded nitroglycerin intravenously and glycoprotein IIb/
IIa inhibitors. During PCI, additional heparin is adminis-
ered guided by activated clotting time measurements.
tandard therapies after PCI included aspirin 80 mg,
lopidogrel 75 mg, beta-blockers, lipid-lowering agents, and
ngiotensin-converting enzyme inhibitors or angiotensin II
eceptor blockers.
ngiographic, electrocardiographic, and clinical out-
ome. Intravenous nitroglycerin was given after the proce-
ure and before the final angiogram in all patients. The
Abbreviations
and Acronyms
CABG  coronary artery
bypass grafting
CK  creatine kinase
ECG  electrocardiogram
IQR  interquartile range
PCI  percutaneous
coronary intervention
STEMI  ST-segment
elevation myocardial
infarction
TIMI  Thrombolysis In
Myocardial InfarctionIMI flow grades will be estimated as previously described:
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260rade 0: no perfusion, grade 1: penetration without perfu-
ion, grade 2: partial perfusion, grade 3: complete perfusion
11). The evaluation of myocardial blush grades will be
erformed as described by van’t Hof et al. (1): grade 0: no
yocardial blush, grade 1: minimal myocardial blush or
ontrast density, grade 2, moderate myocardial blush or
ontrast density but less than that obtained during angiog-
aphy of a contralateral or ipsilateral non–infarct-related
oronary artery, and grade 3, normal myocardial blush or
ontrast density comparable with that obtained during
ngiography of a contralateral or ipsilateral non–infarct-
elated coronary artery. Persisting myocardial blush (stain-
ng) suggests leakage of contrast medium into the extravas-
ular space and is graded 0. Distal embolization was
onsidered to have occurred if new circumscribed filling
efects and/or abrupt cut-off of the vessel distal to the target
esion appears. Thrombus was assessed according to the
riteria summarized by Mabin et al. (12). The coronary
ngiograms were analyzed offline by 2 experienced
bservers.
A 12-lead ECG was acquired at presentation and after
he PCI procedure. The post-procedural ECG was analyzed
y comparison to the ST-segments of the ECG at presen-
ation. ST-segment elevation resolution was categorized as
omplete (70%), partial (30% to 70%), or absent (30%).
ersistent ST-segment deviation, defined as the sum of
T-segment depression and ST-segment elevation, was
ategorized into 2 mm, 2 to 10 mm, and 10 mm.
Clinical status (death, reinfarction, and ischemia-driven
arget vessel revascularization) was collected from hospital
ecords as well as by telephone interviews at 30 days
ost-procedure.
istopathological analysis. Filtered material obtained dur-
ng aspiration was analyzed using the same method as used
n the TAPAS trial. In short, material was placed in
ormalin and fixed for 24 h. Thereafter, filtered material was
elleted by centrifugation in liquid agar 65°C in an Eppen-
orf tube. After the agar pellet was solidified at 4°C, it was
mbedded in paraffin using an automated tissue processor.
araffin sections were cut at 4 m and stained with
ematoxylin-eosin for microscopical examination (100).
mmunostaining was performed to optimize visualization of
ndothelial cells, smooth muscle cells, and macrophage
oam cells. Samples were classified into effective or no
ffective aspiration based on the presence of thrombotic
aterial. Identified material was classified into 4 types:
hrombus with only platelets, thrombus with an erythrocyte
omponent, thrombus with atheromatous plaque, and
hrombus with both erythrocyte and atheromatous plaque
nd in 5 size groups: residue (very small filter casts of loosely
ohesive platelets), well-formed thrombi smaller than 0.5
m, 0.5 to 1 mm, 1 to 2 mm, and 2 mm.
tatistical methods. The primary end point of this study is
he incidence of aspirated thrombotic components 1 mm. wased on earlier experience with the Export catheter (3), it
as estimated that we needed to enroll 160 patients to
chieve a power of 80% (with a 2-sided significance level of
.05) to detect a increase from 35% to 55% with the Diver
atheter.
Values are shown as means  standard deviations, me-
ian (inner quartile range [IQR]), or numbers of patients
percentages). Differences in baseline characteristics and
utcomes were tested using either paired sample t test or
ilcoxon signed-rank test. Nonpaired, univariate, and mul-
ivariate logistic regression analysis were used to assess
ndependent predictors associated with effective thrombus
spiration and histological subsets. Significant variables at
nivariate analysis (p  0.15) were included in multivariate
odels. The following variables were evaluated: gender,
atheter, age, ischemic time, hyperlipidemia, diabetes, cur-
ent smoking, pre-angina pectoris, body mass index,
-vessel disease, TIMI flow grade beforehand, thrombus
isible beforehand, and severe calcification.
All p values were 2-tailed, with statistical significance set
t 0.05. Analyses were performed using SPSS software
ersion 12.0.1 (SPSS Inc., Chicago, Illinois).
esults
total of 82 consecutive patients were included. Two very
oung patients had no matching control patient within 5
ears and were therefore excluded from the analysis. Base-
ine characteristics of the 80 enrolled patients are shown in
able 1.
ngiographic and electrocardiographic outcome. No serious
omplications, such as flow-limiting dissections or air em-
olization, occurred in the Diver or the Export group. A
tent was placed in 91.3% (73 of 80) of the Diver patients
nd in 93.8% (75 of 80) of the Export patients. Direct
tenting (stenting after thrombus aspiration without balloon
re-dilatation) was performed in 42.5% (31 of 73) of the
atients treated with the Diver catheter and in 53.3% (40 of
5) treated with the Export (p  0.39). Distal embolization
ost PCI was seen in 6.3% (5 of 80) of the patients in the
iver group and in 5.8% (4 of 70) in the Export group (p
.74). TIMI flow grade post-procedure and myocardial
lush grade were similar in both groups (Table 1, Fig. 1).
The ECGs for persistent ST-segment deviation analysis
ere available in 92.5% (148 of 160) of the patients and for
T-segment elevation resolution analysis in 91.3% (146 of
60). Median (IQR) time between balloon angioplasty and
ost-PCI ECG was 0.7 (0.5 to 0.9) h in the Diver group
nd 0.7 (0.6 to 1.1) h in the Export group (p  0.37).
ersistent ST-segment deviation 2 mm and 70% ST-
egment elevation resolution was seen in the majority of the
atients treated with thrombus aspiration, respectively
2.0% (77 of 148) and 64.4% (94 of 146). No differences
ere seen in rates of persistent ST-segment deviation 2
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261m, 2 to 10 mm and 10 mm between the Diver (49.3%,
9.7%, and 11.0%) and Export group (54.7%, 33.3%, and
2.0%) (p  0.38) (Fig. 2). Incidences of ST-segment
levation resolution 30%, 30% to 70% and 70% were
lso similar in patients treated with the Diver (15.5%,
6,9%, and 67.6%) and the Export patients (14.7%, 24.0%,
nd 61.3%) (p  0.97) (Fig. 3).
hort-term clinical outcome. Follow-up was completed in
00% of the patients. Occurrence of death, reinfarction, and
arget vessel revascularization within 30 days were similar in
oth groups. One death occurred in the Export group (0%
Table 1. Baseline and Procedural Characteristics
Diver (n 
Age (yrs), mean SD 62.4 12.0
Male gender 61/80 (76
Body mass index (kg/m2), median (IQR) 26.1 (24.2–2
Risk factors
Diabetes 6/79 (7.6
Hypertension 25/78 (32
Hyperlipidemia 24/71 (33
Current smokers 40/79 (50
Family history 43/78 (55
Previous CABG 1/80 (1.3
Previous myocardial infarction 7/80 (8.8
Previous PCI 3/80 (3.8
Pre-infarct angina 42/77 (54
Symptom duration (h), median (IQR) 3.3 (2.0–5.
Hemodynamics pre-procedure, mean SD
Systolic blood pressure 123.5 25.6
Diastolic blood pressure 74.7 14.8
Pulse pressure 81.6 23.9
3-vessel disease 24/78 (30
Peri-procedural glycoprotein IIb/IIIa inhibitors 71/80 (88
Treated vessel
Left anterior descending artery 31/80 (38
Right circumﬂex artery 34/80 (42
Left circumﬂex artery 15/80 (18
Severely calciﬁed lesion 14/80 (17
Birfucation lesion 31/80 (38
TIMI ﬂow grade pre-procedure
0/1 57/80 (71
2 13/80 (16
3 10/80 (12
Thrombus visible pre 43/80 (53
TIMI ﬂow grade 3 post-PCI 70/80 (87
Stent diameter (mm), mean SD 3.3 0.4
Stent length (mm), mean SD 19.9 6.6
Peak CK-MB, median (IQR) 72.8 (28.1–1
Time to peak CK-MB (h), median (IQR) 6.6 (4.3–9.
Peak CK-total, median (IQR) 686.2 (244.4–
Time to peak CK-total (h), median (IQR) 7.2 (4.2–10
CABG coronary artery bypass grafting, CK creatine kinase, IQR interquartile range, PCI pers 1.3%, p  0.32). In the Diver group 2 reinfarctions nccurred, compared with 1 in the Export group (2.5% vs
.3%, p  0.57). Five patients underwent target vessel
evascularizations in the Diver group, compared with 4 in
he Export group (6.3% vs 5.0%, p  0.74). The incidence
f the combined end point of death, reinfarction, or target
essel revascularization was 7.5% (6 of 80) in the Diver
roup versus 6.3% (5 of 80) in the Export group (p  0.76).
istopathological assessment. Effective thrombus aspira-
ion was seen in 70.3% (52 of 74) of the patients treated
ith the Diver catheter versus 81.8% (63 of 77) of the
xport patients (p  0.10). Aspirated thrombotic compo-
Export (n  80) p Value
62.5 11.5 0.94
61/80 (76.3) 1.00
26.2 (24.2–29.3) 0.79
15/79 (19.0) 0.019
26/75 (34.7) 0.85
18/67 (26.9) 0.57
40/73 (54.8) 0.87
44/79 (55.7) 1.00
1/79 (1.3) 1.00
9/79 (11.4) 0.60
7/79 (8.9) 0.16
30/77 (39.0) 0.07
3.2 (2.2–5.6) 0.82
129.7 28.1 0.12
75.1 15.4 0.95
76.6 18.8 0.13
26/77 (33.8) 0.71
77/80 (96.3) 0.08
31/80 (38.8) 1.00
34/80 (42.5) —
15/80 (18.8) —
12/80 (15.0) 0.90
24/80 (30.0) 0.47
54/80 (67.5) 0.49
16/80 (20.0) —
10/80 (12.5) —
40/75 (53.3) 0.87
67/80 (83.8) 0.52
3.4 0.5 0.22
21.3 7.3 0.34
68.0 (27.6–123.0) 0.19
6.8 (5.1–8.8) 0.90
) 764.1 (291.6–1451.8) 0.99
7.1 (5.1–9.9) 0.72
us coronary intervention, SD standard deviation, TIMI Thrombolysis In Myocardial Infarction.80)
.3)
9.4)
)
.1)
.8)
.6)
.1)
)
)
)
.5)
3)
.8)
.8)
.8)
.5)
.8)
.5)
.8)
.3)
.3)
.5)
.8)
.5)
30.0)
9)
1283.4
.9)ents1 mm were found in 44.4% (28 of 63) of the Export
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262atients and in 34.6% (18 of 52) of the Diver patients (p 
.51). The size distribution of retrieved thrombotic particles
as also similar for the 2 devices (p  0.61) (Fig. 4).
Erythrocyte-rich thrombi and thrombi with plaque com-
onents were found in respectively 26.9% (14 of 52) and
.7% (4 of 52) of the patients treated with the Diver and in
2.2% (14 of 63) and 14.3% (9 of 63) of the patients treated
ith the Export catheter. Thrombi with both plaque and
rythrocytes components were seen in 13.5% (7 of 52) of the
iver patients and in 7.9% (5 of 63) of the Export patients.
istribution of histological subsets was similar in the 2
roups (p  0.47).
The relationship between histopathological findings and
aseline characteristics was investigated using logistic re-
ression (Table 2). Thrombus was visible on the initial
ngiogram in the majority of the patients; however, this was
ot associated with retrieval of material at univariate logistic
egression (p  0.70). Multivariate analysis showed that
hrombus aspiration with the Export catheter was not an
Figure 1. Myocardial Blush Grade After Percutaneous Coronary
InterventionFigure 2. Persistent ST-Segment Deviationndependent predictor of effective thrombus aspiration (p 
.09). Independent predictors for erythrocyte-rich thrombi
t multivariate analysis were low initial TIMI flow grade (p
0.008) and absence of 3-vessel disease (p  0.026).
iscussion
his prospective cohort study shows that the Export and
iver catheters are both safe and effective in removing
hrombus in an unselected population with ST-segment
levation myocardial infarction. The larger internal lumen
iameter of the Diver catheter did not result in retrieval of
arger thrombotic particles, nor in improved angiographic or
lectrocardiographic outcomes.
Primary PCI does not always result in successful reper-
usion of the myocardium, despite a patent epicardial vessel.
echanical crushing and fragmentation of the thrombus-
ontaining lesion during primary PCI is thought to be at
east partly responsible for myocardial dysfunction after PCI
Figure 3. ST-Segment Elevation ResolutionFigure 4. Size Distribution of Aspirated Material
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26313–15). Several devices have been introduced to facilitate
emoval of thrombus and plaque material, thereby protect-
ng the microvasculature and improving myocardial blood
ow. In saphenous vein graft PCI, distal embolic protection
evices have proven to be very effective in preventing distal
mbolization (class I recommendation, level of evidence A)
16). In primary PCI for native coronary lesions, aspiration
hrombectomy devices may be most useful because their size
llows access to the lesion over a routine wire. The
EAR-MI (Dethrombosis to Enhance Acute Reperfusion
n Myocardial Infarction) trial randomized 155 patients to
hrombus aspiration with the Pronto catheter or to primary
CI alone (5). Thrombus aspiration in this trial was
ssociated with significantly better ST-segment resolution,
etter myocardial blush grade, and less distal embolization
ompared with primary PCI. The results of the TAPAS
rial (Export aspiration catheter) and the REMEDIA (Ran-
omized Evaluation of the Effect of Mechanical Reduction
f Distal Embolization by Thrombus-Aspiration in Primary
nd Rescue Angioplasty) trial (Diver aspiration catheter),
hich compared thrombus aspiration with primary PCI,
eported also feasibility and applicability of this approach
3,6). Conflicting results came from the trial of Kaltoft et al.
7), which enrolled 215 patients to thrombus aspiration with
he Rescue catheter or primary PCI. This study reported
arger final infarct size and a trend toward less myocardial
alvage associated with thrombus aspiration. In the above-
entioned studies, 4 different aspiration devices were used.
t is unclear to what extent these conflicting results can be
xplained by device-related factors. One major difference
etween these devices is internal lumen diameter. An
spiration catheter with insufficient capacity to aspirate can
heoretically manipulate and dislodge the thrombus, causing
n adverse effect on myocardial perfusion. This present
tudy shows that both medium-lumen and large-lumen
hrombus aspiration catheters are safe and effective in terms
f high rates of myocardial blush grades 2 to 3 and
T-segment normalization.
The size distribution of retrieved particles did not differ
Table 2. Multivariate Logistic Regression Analysis of Significant Baseline
Characteristics (p < 0.15) on Effective Thrombus Aspiration and
Erythrocyte-Rich Thrombi
Dependent
Variable Covariable
Exp(B)
(95% CI) p Value
Effective thrombus
aspiration
Catheter (Export) 2.07 (0.90–4.76) 0.09
Diabetes 0.39 (0.13–1.14) 0.08
Hyperlipidemia 0.48 (0.21–1.11) 0.09
Erythrocyte-rich
thrombi
Ischemic time (hrs) 1.07 (0.98–1.18) 0.15
3-vessel disease 0.32 (0.12–0.87) 0.026
TIMI ﬂow pre 0.54 (0.34–0.85) 0.008
CI  confidence interval; Exp (B)  exponentiation of the B coefficient; TIMI  Thrombolysis In
Myocardial Infarction; pre before angioplasty procedure.ignificantly between the 2 catheters; however, especially in she range 1 to 2 mm, some difference could be detected in
avor of the Export catheter. These differences can be caused
y differences in distal tip design between the 2 catheters.
he nonsuperiority of a larger-lumen catheter may be
xplained by the fact that freshly formed thrombi are easily
riable. Whether a larger-lumen catheter has a benefit in the
ontext of older occlusions and degenerated saphenous vein
rafts, in which particles are less friable, is currently unclear.
Previous angioscopic studies in patients with acute coro-
ary syndromes suppose erythrocyte-rich thrombi to be
resent in the majority of the patients with acute myocardial
nfarction (17,18). Our study found a lower incidence of
rythrocyte-rich thrombi (34.8%, 40 of 115). Erythrocyte-
ich thrombi were predominantly seen in patients with low
nitial epicardial flow in combination with a trend for longer
schemic time. This supports the thought that erythrocyte-
ich thrombi are formed mainly during stasis of blood flow,
hereas white thrombi are predominately seen in patients
ith TIMI flow grade 1 to 3 at presentation (17–20). The
ower incidence of erythrocyte-thrombi in our study can be
xplained by the fact that most previous observations date
rom the thrombolytic era, whereas nowadays patients are
retreated with heparin, aspirin, and clopidogrel during
ransportation to a PCI facility. These antithrombotic
gents can induce enhancement of lysis and dissolvement of
hrombus, causing pharmacological reperfusion before the
nitial angiogram (21,22).
In our study we compared 2 manual thrombus-aspiration
atheters. However, there are several types of adjunctive
echanical devices for reducing distal embolization. Re-
ently a meta-analysis has been published combining the
esults of 21 randomized trials investigating the impact of
djunctive mechanical devices to prevent distal embolization
4). In this analysis, the benefit in terms of better myocardial
erfusion and less distal embolization was more apparent in
tudies investigating the impact of thrombectomy as com-
ared with distal protection devices. Whether there is a
ifference in efficacy between different types of adjunctive
echanical devices (for example, mechanical thrombectomy
s manual thrombus aspiration) is currently unclear in the
ontext of STEMI, because no direct comparisons have
een performed.
This study has several limitations. Both study groups
ere followed up prospectively and matched for age, gender,
nitial TIMI flow grade, and infarct-related segment, but
ias of unknown confounders still might exist. Our his-
opathological analysis provides information on aspiration
apacity in terms of presence of thrombotic material and
ize of aspirated particles. However, no analysis was per-
ormed on the total volume of retrieved debris. A distal
mbolic protection device may be useful for investigating
ifferences in the volume ratio of aspirated versus distal
mbolic debris, but these devices are only feasible in a
elected group of patients.
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264onclusions
he present study shows that manual aspiration catheters
re safe and effective in removing thrombus in patients with
T-segment elevation myocardial infarction. A larger inter-
al lumen diameter did not result in retrieval of larger
hrombotic particles, nor in improved angiographic or
lectrocardiographic outcomes.
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